About BostonGene
BostonGene is a company based in Waltham (United States) founded in 2015.. BostonGene has raised $200 million across 2 funding rounds from investors including NEC, Impact Investment Exchange and Japan Industrial Partners. BostonGene offers products and services including BostonGene Tumor Portrait™ Test, Liquid Biopsy, and Immunohistochemistry (IHC) Test. BostonGene operates in a competitive market with competitors including Helix, Syapse, Benchling, BioAge Labs and Ingenuity Systems, among others.
- Headquarter Waltham, United States
- Stage Unicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bostongene Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$200 M (USD)
in 2 rounds
-
Latest Funding Round
$150 M (USD), Series B
Apr 06, 2022
-
Investors
NEC
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BostonGene
BostonGene offers a comprehensive portfolio of products and services, including BostonGene Tumor Portrait™ Test, Liquid Biopsy, and Immunohistochemistry (IHC) Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers comprehensive molecular profiling for cancer patients
Provides non-invasive testing for tumor analysis
Detects actionable biomarkers in cancer samples
Unlock access to complete
Software Development Team
18 people
Sales and Marketing
14 people
Leadership Team
12 people
Product Management Team
7 people
Data Analysis and Operations Team
6 people
Human Resources and Administration
5 people
Senior Team
5 people
Medical Team
4 people
Unlock access to complete
Funding Insights of BostonGene
BostonGene has successfully raised a total of $200M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $150 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $150.0M
-
First Round
First Round
(24 Apr 2019)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Series B - BostonGene | Valuation | NEC | |
| Apr, 2019 | Amount | Series A - BostonGene | Valuation | NEC |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BostonGene
BostonGene has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include NEC, Impact Investment Exchange and Japan Industrial Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward women empowerment initiatives.
|
Founded Year | Domain | Location | |
|
Japan Industrial Partners is engaged in industrial revitalization and growth.
|
Founded Year | Domain | Location | |
|
Cloud-based IT and networking solutions are provided globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BostonGene
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BostonGene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bostongene Comparisons
Competitors of BostonGene
BostonGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Syapse, Benchling, BioAge Labs and Ingenuity Systems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Developer of precision medicine for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| domain | founded_year | HQ Location |
AI-based omics data analysis solutions are provided to researchers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BostonGene
When was BostonGene founded?
BostonGene was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Where is BostonGene located?
BostonGene is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Is BostonGene a funded company?
BostonGene is a funded company, having raised a total of $200M across 2 funding rounds to date. The company's 1st funding round was a Series A of $50M, raised on Apr 24, 2019.
What does BostonGene do?
BostonGene was founded in 2015 and is headquartered in Waltham, United States. Operations focus on the healthcare and biotechnology sectors, where a cloud-based platform integrates AI, algorithms, and modern technologies. Molecular profiles of patient tumors are analyzed, combining tumor microenvironment, genetic data, and clinical information. Results are delivered directly to medical professionals through the MF Portrait platform to support oncology decisions.
Who are the top competitors of BostonGene?
What products or services does BostonGene offer?
BostonGene offers BostonGene Tumor Portrait™ Test, Liquid Biopsy, and Immunohistochemistry (IHC) Test.
Who are BostonGene's investors?
BostonGene has 3 investors. Key investors include NEC, Impact Investment Exchange, and Japan Industrial Partners.
What is BostonGene's valuation?
The valuation of BostonGene is $1B as of Apr 2022.